Here's What These $3 Billion Money Managers Have Been Buying

It can pay off to keep an eye on the big guys.

May 12, 2014 at 11:00AM

Every quarter, many money managers have to disclose what they've bought and sold via "13F" filings. Their latest moves can shine a bright light on smart stock picks.

Today, let's look at Todd Asset Management. Based in Kentucky, the money managers' investing philosophy centers around their estimate of price in relation to intrinsic value. They add: "We believe investing in stocks with attractive valuation, improving fundamentals and market acceptance of those characteristics increases the probability of outperformance."

The company's reportable stock portfolio totaled $3.5 billion in value as of March 31, 2014.

Interesting developments
So what does Todd Asset Management's latest quarterly 13F filing tell us? Here are a few interesting details:

New holdings of interest include Qiwi PLC (NASDAQ:QIWI) and Xerox Corp (NYSE:XRX). You may not have heard of Russia-based Qiwi PLC, as it has been on the market for less than a year. But you might want to be aware of it, as it sports a market cap near $1.6 billion and pays out a whopping 4.4% dividend yield. The company is in the online payment systems business, with more than 125,000 kiosks and over 40,000 terminals. The stock has tumbled lately on worries that sanctions on Russia will hamper its business. In March the company posted fourth-quarter results, with revenue up 35% and profit up 33%. Be wary of that dividend, though, as it surpasses the company's earnings per share. That's OK so long as the company keeps growing briskly.

Xerox, meanwhile, offers a 2.1% dividend yield, but it's paying out less than a third of its earnings. The company is saddled with a lot of debt, but it's been working on turning itself around by shedding some non-core assets and shifting its focus from hardware to high-margin services. (Services recently made up about 57% of revenue.) The company isn't growing briskly at this point, but it's generating a lot of cash flow and seems appealingly priced, with its forward P/E near nine. Critics don't like CEO Ursula Burns' compensation, which has topped $10 million for several years in a row, and some worry about recent insider sales, too. Xerox surpassed estimates with its first-quarter earnings, but revenue fell 2%, and management pared back near-term guidance.

Among holdings in which Todd Asset Management increased its stake was Hewlett-Packard Company (NYSE:HPQ). The printing giant recently got a positive analyst report from Pacific Crest Securities -- its first one in 10 years from the firm -- with analyst Brent Bracelin seeing improving profitability and expecting IBM's exit from the x86 server market to be beneficial to HP. Hewlett-Packard has been hurt by the weak PC market and has been cutting costs aggressively as it aims to expand in areas such as 3-D printing and health care analytics. Its last quarter featured estimate-topping revenue and earnings, with earnings rising 10% over year-ago levels and revenue dropping by 1%. Hewlett-Packard's future is rather uncertain.

Todd Asset Management reduced its stake in lots of companies, including security specialist ADT Corp. (NYSE:ADT), which yields 2.6%. ADT has been struggling in recent years and is saddled with a lot of debt. The company recently reported second-quarter earnings that topped expectations, but they were lower than in the year-ago quarter. Indeed, revenue and earnings have been shrinking for several years as the company faces stronger competition, including some from an unlikely rival: cable companies. It has been cutting costs but also spending a lot on share buybacks. It also upped its dividend by 60% recently. ADT stock is heavily shorted -- and deservedly so, says my colleague Sean Williams.

Finally, Todd Asset Management's closed positions of interest include Celgene Corporation (NASDAQ:CELG), a biotech company that produces successful anemia drug Revlimid and pancreatic cancer drug Abraxane, as well as a recently approved arthritis drug, Otezla. Celgene is investing heavily in other companies with promising early stage drugs, such as a formula tackling Crohn's disease. My colleague Stephen Simpson has noted that Celgene has "a deep early-stage pipeline of oncology drugs" and "meaningful label expansion opportunities for approved drugs." The company surpassed earnings expectations in its last quarter, but its revenue lagged.

We should never blindly copy any investor's moves, no matter how talented the investor. But it can be useful to keep an eye on what smart folks are doing. 13F forms can be great places to find intriguing candidates for our portfolios.

Warren Buffett just bought nearly 9 million shares of this company
Imagine a company that rents a very specific and valuable piece of machinery for $41,000 per hour (that's almost as much as the average American makes in a year!). And Warren Buffett is so confident in this company's can't-live-without-it business model, he just loaded up on 8.8 million shares. An exclusive, brand-new Motley Fool report reveals the company we're calling "OPEC's Worst Nightmare." Just click here to uncover the name of this industry-leading stock and join Buffett in his quest for a veritable LANDSLIDE of profits!

Longtime Fool specialist Selena Maranjian, whom you can follow on Twitter, owns shares of Apple and Celgene. The Motley Fool recommends Apple and Celgene. It owns shares of Apple and International Business Machines. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information